KateTx debuted less than a year ago with a $51 million Series A round co-led by Westlake Village BioPartners and Versant ...

Novo Nordisk and Metaphore Biotechnologies will partner to develop obesity management treatments in an up-to-$600 ...

Mass photometry is a high-throughput technique with fast run times in the region of 60 seconds and no need for labeling.

Researchers say new yeast biosynthetic platform provides "vast opportunities" to produce structural variants of QS-21 and ...

A number of methods will be used for cell therapies, especially in cell expansion. Autologous and allogeneic therapies have ...

New study suggests that a subset of cancers with high levels of PI3KR5 expression might respond better to an experimental immunotherapy.

Digitalization and automation are the major drivers to reduce cycle times and costs, and increase the overall work in progress.

We catch up with Mammoth Biosciences CSO Lucas Harrington after his ASGCT presentation. Harrington lays out his company's big plans in developing a range of therapeutic options using miniature Cas ...

The Crick Institute plans to leverage Broken String’s DNA break-mapping platform to develop novel applications for ALS treatments.

Pfizer has paused enrollment in a Phase III trial assessing its Duchenne muscular dystrophy (DMD) gene therapy candidate ...

Metagenomic study uncovers previously uncharacterized Cas9 nucleases, including CoCas9, which is compact, but still active ...

Internal neural compass which the human brain uses to orientate itself in space and navigate through the environment has been ...